Decoy Therapeutics Inc. (DCOY) SEC Filings & Financial Intelligence
Decoy Therapeutics Inc. (DCOY) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: DCOY
CIK: 1615219
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Ernst & Young LLP
Auditor SinceSince 12/31/2016 12:00:00 AM
Lead Engagement PartnerChase Gentry
Audit LocationHouston, Texas, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 424B3 | 2026-10-16 | — | 424B3 | 0001193125-26-424075 | View SEC Doc Filr Page |
| S-1 | 2026-10-07 | — | S-1 | 0001193125-26-417053 | View SEC Doc Filr Page |
| 8-K | 2026-09-23 | 2026-09-22 | 8-K | 0001615219-26-000019 | View SEC Doc Filr Page |
| 8-K | 2026-09-15 | 2026-09-14 | 8-K | 0001615219-26-000016 | View SEC Doc Filr Page |
| 4 | 2026-09-02 | 2026-08-31 | 4 | 0001193125-26-380584 | View SEC Doc Filr Page |
| 4 | 2026-09-02 | 2026-08-31 | 4 | 0001229055-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-09-02 | 2026-08-31 | 4 | 0002079859-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-09-02 | 2026-08-31 | 4 | 0001329154-26-000003 | View SEC Doc Filr Page |
| 4 | 2026-09-02 | 2026-08-31 | 4 | 0002079512-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-09-02 | 2026-08-31 | 4 | 0001233253-26-000006 | View SEC Doc Filr Page |
| 4 | 2026-09-02 | 2026-08-31 | 4 | 0001457289-26-000003 | View SEC Doc Filr Page |
| 4 | 2026-09-02 | 2026-08-31 | 4 | 0001769749-26-000003 | View SEC Doc Filr Page |
| 4 | 2026-09-02 | 2026-08-31 | 4 | 0001634368-26-000003 | View SEC Doc Filr Page |
| 4 | 2026-09-02 | 2026-08-31 | 4 | 0002148287-26-000002 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-14 | — | SCHEDULE 13G Filing | 0001172661-26-003569 | View SEC Doc Filr Page |
| 10-Q | 2026-08-12 | 2026-06-30 | 10-Q | 0001193125-26-346852 | View SEC Doc Filr Page |
| DEF 14A | 2026-08-04 | 2026-09-14 | DEF 14A | 0001193125-26-332762 | View SEC Doc Filr Page |
| DEFA14A | 2026-08-04 | — | DEFA14A | 0001193125-26-332792 | View SEC Doc Filr Page |
| 3 | 2026-07-31 | 2026-07-14 | 3 | 0001193125-26-328787 | View SEC Doc Filr Page |
| PRE 14A | 2026-07-24 | 2026-07-24 | PRE 14A | 0001193125-26-316072 | View SEC Doc Filr Page |
| EFFECT | 2026-07-17 | — | EFFECT Filing | 9999999995-26-002352 | View SEC Doc Filr Page |
| 424B3 | 2026-07-17 | — | 424B3 | 0001193125-26-307982 | View SEC Doc Filr Page |
| 8-K | 2026-07-15 | 2026-07-14 | 8-K | 0001193125-26-304949 | View SEC Doc Filr Page |
| S-1 | 2026-07-10 | — | S-1 | 0001193125-26-300954 | View SEC Doc Filr Page |
| 8-K | 2026-06-29 | 2026-06-26 | 8-K | 0001193125-26-286737 | View SEC Doc Filr Page |